GENEVIEVE TAGUINOD: Open Payments
NPI 1598956815 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,651 in 102 payments from 27 companies in 2025. Trend: 2023 $2,280 · 2024 $2,412 · 2025 $2,651
Food & beverage: $2,432Education: $219
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $429 |
| ABBVIE INC. | 12 | $252 |
| Novartis Pharmaceuticals Corporation | 12 | $227 |
| Incyte Corporation | 7 | $194 |
| Daiichi Sankyo Inc. | 7 | $180 |
| Merck Sharp & Dohme LLC | 7 | $149 |
| BeOne Medicines USA, Inc. | 4 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $97 |
| Astellas Pharma US Inc | 1 | $91 |
Products named: Enhertu, EPKINLY, CALQUENCE, KEYTRUDA, KISQALI, BRUKINSA, LIBTAYO, MONJUVI.
Industry payments across CA — which companies pay providers there.
